Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat
about
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathologyHistone deacetylase 7 (Hdac7) suppresses chondrocyte proliferation and β-catenin activity during endochondral ossificationHistone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionThe Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity.Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1Parathyroid hormone regulates histone deacetylase (HDAC) 4 through protein kinase A-mediated phosphorylation and dephosphorylation in osteoblastic cellsRunx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.Histone deacetylases in skeletal development and bone mass maintenance.HDAC3 and HDAC7 have opposite effects on osteoclast differentiationSkeletal defects in Osterix-Cre transgenic mice.Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.Interpreting clinical assays for histone deacetylase inhibitors.Osterix-Cre transgene causes craniofacial bone development defectFOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.Hdac-mediated control of endochondral and intramembranous ossificationConditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.Histone Deacetylases in Bone Development and Skeletal Disorders.Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression.Histone deacetylase 3 is required for maintenance of bone mass during agingHdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor CellsEpigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient miceHistone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretionPhlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis.Conditional ablation of HDAC3 in islet beta cells results in glucose intolerance and enhanced susceptibility to STZ-induced diabetesMultiple roles of class I HDACs in proliferation, differentiation, and development.Transcription and beyond: the role of mammalian class I lysine deacetylasesClass I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy.Histone Deacetylases in Cartilage Homeostasis and Osteoarthritis.Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing.The Roles of Long Non-Protein-Coding RNAs in Osteo-Adipogenic Lineage Commitment.Histone H3K9 Acetyltransferase PCAF Is Essential for Osteogenic Differentiation Through Bone Morphogenetic Protein Signaling and May Be Involved in Osteoporosis.Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression.The Effects of Class-Specific Histone Deacetylase Inhibitors on the Development of Limbs During Organogenesis.Histone deacetylases and their roles in mineralized tissue regeneration
P2860
Q26741198-841B6F65-EB51-4796-AD8F-CBCD85973C35Q27010162-29BF4ADF-5625-4A13-B08B-DF6D7FAE40FCQ28251460-C32B287C-1AC6-413F-81B9-5BDE3603767BQ28505369-1EEA6894-4A1F-4A09-A3D1-F5700BD4353EQ30540974-8A1C9303-8390-44A4-9A39-098ABD4FCF84Q33614697-4322C419-4DA6-4E59-9E8A-36F5938FA858Q33784471-448518FB-3637-4DF7-B4A8-A5D7BAD638ADQ33985257-0DBF9356-B5E4-41E9-B984-6C6C1194A227Q34016769-20D2367A-EFAB-49EF-A7F6-5D33832791CEQ34437672-A8AE5312-122B-4DFD-A9C1-5F94FC7D1BA7Q34439684-8328C4B4-39AB-46BB-8FEF-6ED43D643297Q34612849-77069F31-658D-4D7D-B7E2-131C6E3EF2F9Q34752049-92837073-EA90-4C5D-94B6-0E7A9CD92065Q34771579-D336DE37-D8D7-4A77-AE40-323B87388DDCQ34810920-16FFFA49-296A-428B-B54A-9201D89F9ECCQ35003657-7EE6F5A5-BD67-4DB3-96C9-A57E1A2EF4C9Q35060734-2A20A957-5993-4028-91C1-60377EE43592Q35183865-062C769B-CEF9-4A3C-8B68-5FA1107AB573Q35556841-34FDF09A-2A24-4F02-AFE3-78918C0F6041Q35648782-928EA7C9-62DC-4DB2-8715-034864DD9B88Q35783129-EDF958C3-A13C-4086-BF9F-ADA36F88D647Q36146330-9923E335-5E64-411B-8ED9-6071D4081394Q36181298-9AB7DBF4-7E25-45A0-8BA4-3E062E876853Q36442972-21E72861-657C-4898-9DC9-758A70814362Q36593452-0DC911FE-BCED-4F72-BA62-EEBE995B7457Q36613056-3A75BE02-2B6E-435E-B8BC-3F9BF087E65FQ36635990-870E7A57-89A7-45DF-AFF0-AE814D9A6DE5Q36742145-78883B72-ECBF-4F12-8D30-D39479C931ADQ36923747-08D19BF3-3EF4-466C-B191-25265552D435Q37628891-27F438B5-C178-4970-BF53-9412E3F6ACCAQ37979639-ED77EA02-670D-4DB8-B69D-377EFFE69116Q38156341-9389CC4E-CDA0-4A26-BCBC-5F878FD149DBQ38204487-ABC7705C-04BD-4C5D-B03D-7BDEB2E1B6EDQ38893201-AD604B47-51DD-4D14-B94F-CC85E931C003Q38993135-6FD252D5-FB85-4153-B693-7B4AE2A327D2Q39362068-A6B49E6B-7312-41F0-9FC9-F0AFD2010CCDQ40382280-69B4E275-2FE7-4538-BA1B-3791FFF980D9Q40644814-DF6812E7-6EA4-47B4-8C9D-AE76CFC08593Q40649592-693B30BD-53B2-4353-8C87-7A11937CE6BAQ41479037-4E3037E5-3C9F-45FA-B125-A5859F1B24DF
P2860
Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@ast
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@en
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@nl
type
label
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@ast
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@en
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@nl
prefLabel
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@ast
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@en
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@nl
P2093
P2860
P3181
P1433
P1476
Histone deacetylase 3 depletio ...... nsity and increases marrow fat
@en
P2093
Bridget A Stensgard
David F Razidlo
Frank J Secreto
Jennifer J Westendorf
Michelle E Casper
Sarah K Knutson
Scott W Hiebert
Tiffany J Whitney
Xiaodong Li
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0011492
P407
P577
2010-01-01T00:00:00Z